We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor.
- Authors
Piccioni, Federica; Roman, Benjamin R.; Fischbeck, Kenneth H.; Taylor, J. Paul
- Abstract
Spinobulbar muscular atrophy is a neurodegenerative disorder caused by expansion of a CAG triplet repeat sequence encoding a polyglutamine tract in the androgen receptor. It has been shown that the mutant protein is toxic in cell culture and triggers an apoptotic cascade resulting in activation of caspase-3. We developed an assay of caspase-3 activation in cells expressing the mutant androgen receptor. This assay was used to screen 1040 drugs, most of which are approved for clinical use. Drugs that inhibit polyglutamine-dependent activation of caspase-3 were subjected to follow-up screens to identify compounds that reproducibly prevent polyglutamine-induced cytotoxicity. Four drugs satisfied these criteria. Three of these (digitoxin, nerifolin and peruvoside) are structurally and functionally related compounds of the cardiac glycoside class and known inhibitors of Na+K+-ATPase. The fourth compound, suloctidil, is a calcium channel blocker.
- Publication
Human Molecular Genetics, 2004, Vol 13, Issue 4, p437
- ISSN
0964-6906
- Publication type
Article